Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 5016

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.27, p 0.489). This receipt's hash covers every field on it, plus the hash of receipt 5015, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 5016
    21 Oct 2026, 06:08 UTC

    CELSR3

    dopamine neurons, braak

    predictionCELSR3 in dopamine neurons tracks Braak Lewy-body stage

    registeredc9d52f1c6a192ee2

    discovery-0.27 p=0.489 n=9

    replication-0.27 p=0.476 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.27, p 0.489)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    47506510a6e4144a8b84cf3d…
    follows 60cc58abb5b9…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 5016: CELSR3 in dopamine neurons, braak

power
full sample -0.27 (p 0.273, n 18), 95% CI -0.66 to +0.22. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.27 (p 0.273, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.28 (p 0.254, n 18). could be the mix.
skeptic
leave-one-out range -0.42 to -0.18, sign flips 0; without severely affected donors -0.27 (p 0.273, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for CELSR3 in dopamine neurons.

case closed: nothing better to follow up.